Q1 EPS Estimates for CVS Health Decreased by Leerink Partnrs

by · The Markets Daily

CVS Health Co. (NYSE:CVS – Free Report) – Equities researchers at Leerink Partnrs decreased their Q1 2025 earnings per share (EPS) estimates for shares of CVS Health in a report released on Wednesday, November 6th. Leerink Partnrs analyst M. Cherny now expects that the pharmacy operator will earn $1.41 per share for the quarter, down from their prior estimate of $1.49. The consensus estimate for CVS Health’s current full-year earnings is $6.27 per share. Leerink Partnrs also issued estimates for CVS Health’s Q2 2025 earnings at $1.64 EPS, Q4 2025 earnings at $1.68 EPS and FY2025 earnings at $6.65 EPS.

Other analysts have also issued research reports about the stock. Cantor Fitzgerald reissued a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a research report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft decreased their target price on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Royal Bank of Canada restated an “outperform” rating and issued a $68.00 price target on shares of CVS Health in a research note on Wednesday, September 4th. UBS Group lifted their target price on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday. Finally, Truist Financial lifted their price target on CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a report on Friday, October 11th. Nine investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $73.00.

Check Out Our Latest Research Report on CVS Health

CVS Health Stock Performance

Shares of CVS Health stock opened at $57.11 on Friday. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. The firm has a market cap of $71.84 billion, a price-to-earnings ratio of 14.49, a price-to-earnings-growth ratio of 0.82 and a beta of 0.55. CVS Health has a one year low of $52.77 and a one year high of $83.25. The stock’s 50-day moving average is $59.59 and its 200-day moving average is $59.23.

CVS Health (NYSE:CVS – Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The firm’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period last year, the business posted $2.21 earnings per share.

Institutional Trading of CVS Health

Several hedge funds have recently modified their holdings of CVS. Prospera Financial Services Inc boosted its position in shares of CVS Health by 5.8% during the 3rd quarter. Prospera Financial Services Inc now owns 34,555 shares of the pharmacy operator’s stock worth $2,174,000 after purchasing an additional 1,908 shares in the last quarter. Meeder Asset Management Inc. boosted its holdings in CVS Health by 2,925.0% in the third quarter. Meeder Asset Management Inc. now owns 10,285 shares of the pharmacy operator’s stock worth $647,000 after acquiring an additional 9,945 shares in the last quarter. OneAscent Financial Services LLC acquired a new stake in CVS Health in the third quarter valued at approximately $309,000. Pathstone Holdings LLC raised its position in shares of CVS Health by 2.0% during the third quarter. Pathstone Holdings LLC now owns 222,285 shares of the pharmacy operator’s stock worth $13,977,000 after purchasing an additional 4,432 shares during the period. Finally, Amara Financial LLC. bought a new stake in CVS Health during the 3rd quarter valued at $354,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.66%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

CVS Health Company Profile

(Get Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Read More